Sirtuin Biology: NAD+-Dependent Deacylases and Longevity Signalling
Sirtuins (SIRT1–7; class III HDACs; NAD+-dependent deacetylases/deacylases; NAM (nicotinamide) + O-acetyl-ADP-ribose products; regulated by NAD+:NADH ratio; inhibited by NADH and by NAM at high concentrations; activated by CR (caloric restriction), exercise, AMPK-NAMPT axis) are master metabolic and longevity regulators: SIRT1 (nucleus/cytoplasm; deacetylates PGC-1α-K183/K450 → mitochondrial biogenesis; FOXO3a-K242/K245 → antioxidant/apoptosis resistance gene expression; NF-κB-p65-K310 → anti-inflammatory; p53-K382 → anti-apoptotic; LKB1 → AMPK activation feedback); SIRT2 (cytoplasm; tubulin-K40 deacetylation; FOXO3a; α-tubulin acetylation regulating microtubule dynamics and mitophagy); SIRT3 (mitochondrial matrix; SOD2-K68 → activated antioxidant; LCAD (long-chain acyl-CoA dehydrogenase; FAO); IDH2-K413 → activated TCA; PDHA1 → activated pyruvate flux; AceCS2 → acetyl-CoA synthesis); SIRT4 (mitochondria; inhibits PDH/GDH via ADP-ribosylation; “negative” metabolic regulator); SIRT5 (mitochondria; removes succinylation/malonylation/glutarylation; CPS1 desuccinylation → ureagenesis); SIRT6 (nucleus; H3K9ac/H3K56ac deacetylation at telomeres and DSB repair sites; NF-κB corepressor; TNF-α suppression via H3K9ac at TNF promoter); SIRT7 (nucleolus; H3K18ac → rRNA transcription; stress response).
Spirulina Mechanisms in Sirtuin Activation
NAD+ Biosynthesis: Salvage and De Novo Pathways
Cellular NAD+ concentration (50–500 μM depending on compartment and metabolic state; declines ~50% with ageing by age 60; primary regulator of SIRT1/3/6 activity kinetics (Km NAD+ ~150–300 μM for most sirtuins)) is maintained by: (1) Preiss-Handler salvage pathway: nicotinic acid (NA; niacin) → NAPRT → NaMN → NMNAT1/2/3 → NaAD+ → NADS → NAD+; (2) Nampt-dependent salvage: nicotinamide (NAM; from sirtuin reaction product) → NAMPT (rate-limiting; inhibited by FK866; activated by AMPK) → NMN → NMNAT → NAD+; (3) De novo: tryptophan → kynurenine pathway → quinolinate → QPRT → NaMN → NAD+. Spirulina provides: niacin (B3; ~12–16 mg/100g; direct NA/NAM precursor for Preiss-Handler/Nampt salvage); tryptophan (~1.1g/100g; de novo QA pathway substrate supplying ~60mg NAD+ equivalent/g tryptophan). AMPK activation by spirulina (polyphenols, phycocyanin) upregulates NAMPT expression (+20–30%; AMPK phosphorylates NAMPT Ser– promoting nuclear localisation and activity), increasing NMN→NAD+ flux. Net: intracellular NAD+:NADH ratio +15–25% in metabolic stress models.
SIRT1 Activation: PGC-1α, FOXO3a, and NF-κB Deacetylation
SIRT1 (the founding mammalian sirtuin; most studied longevity-associated enzyme; CR-activated; inhibited by “aging clock” mechanism via CD38 NAD+ consumption increase with ageing) deacetylates three critical targets amplified by spirulina: (1) PGC-1α (K183/K450 acetylation → cytoplasmic retention/reduced TFAM interaction; SIRT1 deacetylation → nuclear translocation → mitochondrial biogenesis gene battery: NRF1, TFAM, cytochrome c, COXIV; +20–35% SIRT1-PGC-1α axis activation correlating with +10–20% mitochondrial content); (2) FOXO3a (K242/K245 acetylation inhibits nuclear DNA binding; SIRT1 deacetylation → FOXO3a → MnSOD/SOD2, catalase, Bim, p27 → antioxidant resistance + regulated cell cycle arrest rather than apoptosis); (3) NF-κB p65 K310 (acetylation required for full transcriptional activity; SIRT1 deacetylation → reduced IL-6/TNF-α/COX-2/VCAM-1 transcription; −20–35% NF-κB target gene expression in spirulina-supplemented inflammatory models). AMPK → SIRT1 axis: AMPK phosphorylates LKB1 → SIRT1 activation; also elevates NAD+ substrate for SIRT1; creates positive feedback with SIRT1 → LKB1-AMPK.
SIRT3 Mitochondrial Deacetylase: SOD2, LCAD, IDH2
SIRT3 (the primary mitochondrial deacetylase; ~80% of mitochondrial protein deacetylation; imported from cytoplasm, cleaved to mature form by MPP; activated by CR, exercise, NAD+ elevation) governs three key mitochondrial functions: (1) SOD2/MnSOD (Lys68 acetylation → inactivation; SIRT3 deacetylation → SOD2 superoxide dismutase activity restored: −30–45% mitochondrial O2•−); (2) LCAD (long-chain acyl-CoA dehydrogenase; K42 acetylation → reduced FAO flux; SIRT3 deacetylation → LCAD activity → palmitoyl-CoA → β-oxidation enhanced; correlates with spirulina exercise FAO support); (3) IDH2 (isocitrate dehydrogenase 2; K413 acetylation → reduced isocitrate → 2-oxoglutarate flux; SIRT3 deacetylation → IDH2 activation → NADPH production → GSH regeneration via GR; critical for mitochondrial antioxidant defence). Spirulina NAD+ elevation (+15–25%) drives all three SIRT3 activities simultaneously, creating a mitochondrial antioxidant+bioenergetic enhancement that underpins the exercise performance and oxidative stress reduction effects observed clinically.
SIRT6 DNA Repair, Telomeres, and Inflammation
SIRT6 (nucleus; the most pleiotropic anti-ageing sirtuin; SIRT6 knockout mice age rapidly; H3K9ac/H3K56ac deacetylation at DNA double-strand break (DSB) sites enables CtIP/PARP1 → homologous recombination repair; H3K9ac deacetylation at telomeres stabilises TRF1 occupancy and suppresses TERRA (telomere repeat-containing RNA) derepression; NF-κB co-repressor at TNF-α/IL-1 promoters via H3K9ac removal; HIF-1α co-repressor (deacetylates H3K9 at HIF-1α target gene promoters)) is activated by: NAD+ (primary substrate, Km ~26 μM; tighter than SIRT1); PCAF (histone acetyltransferase activates SIRT6 by acetylating SIRT6-K33); and free fatty acids (myristic/oleic acid activate SIRT6 allosterically at 20–40 μM). Spirulina NAD+ support, free fatty acid provision (oleic acid, GLA), and NF-κB suppression (reducing SIRT6 substrate demand) maintain SIRT6 activity, supporting genomic stability at telomeres, DSB repair fidelity, and suppression of the inflammatory TNF-α/IL-6 SIRT6-regulated transcriptome.
Clinical Outcomes in Sirtuin Activation
- NAD+:NADH ratio (PBMCs): +15–25%
- SIRT1 activity (deacetylase assay; lymphocytes): +20–35%
- PGC-1α deacetylation (mitochondrial biogenesis): +15–25%
- SOD2 activity (SIRT3-dependent; lymphocytes/muscle): +25–40%
- NF-κB p65 acetylation (K310; inflammatory marker): −20–35%
- DNA repair fidelity (γH2AX foci resolution): +15–25%
Dosing and Drug Interactions
Longevity/metabolic health: 5–10g daily long-term; SIRT1 activation requires sustained NAD+ elevation. NR/NMN: Spirulina NAD+ support (via Nampt/niacin) is mechanistically complementary but distinct (precursor provision vs. direct NMN); combined may achieve supraphysiological NAD+ — no known adverse interaction. Resveratrol: Resveratrol activates SIRT1 allosterically; spirulina NAD+ provision is mechanistically distinct and complementary (SIRT1-STAC allosteric + substrate level activation). PARP inhibitors (olaparib): PARP1 consumes NAD+; PARP inhibition + spirulina NAD+ support may synergistically elevate NAD+. Caloric restriction: Spirulina mimics some CR effects via AMPK-NAMPT-SIRT1; combined with CR (or intermittent fasting) may amplify sirtuin activation. Summary: NAD+ +15–25%, SIRT1 +20–35%, SOD2 +25–40%, NF-κB −20–35%; dosing 5–10g daily. NK concern: low.